Literature DB >> 17939336

IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.

Do-Hyoung Kim1, Tae-Young Kim, Sun-Min Kim, Soo-Jeong Yoo, Dong-Jin Oh, Suk-Hee Yu.   

Abstract

BACKGROUND: We investigated whether the presence of diabetes mellitus (DM) was related to the degree of the anemia in predialytic patients with renal failure and what was the most relevant factor for anemia in patients with chronic kidney disease (CKD) from DM (DM-CKD).
METHODS: Seventy seven patients (47 predialytic patients with long-term type 2 DM (DM-CKD) and 30 predialytic patients whose disease was due to other causes (non DM-CKD)) were enrolled in this study. The blood hemoglobin (Hb) and hematocrit, and the creatinine, ferritin, vitamin B12, folate, iron, LDH, albumin, hs-CRP, intact-PTH, erythropoietin, leptin and Insulin-like growth factor I (IGF-1) levels were measured using standard methods. The estimated GFR was calculated using the abbreviated MDRD equation.
RESULTS: The two groups did not significantly differ as to age, gender, the serum creatinine level and the inflammatory status. The Hb level was significantly lower in the DM-CKD patients than that in the non DM-CKD patients (8.5+/-1.7 g/dL vs 9.6+/-1.6 g/dL, respectively, p=0.01). The Hb level was significantly lower in the DM-CKD patients who were being treated with ACE inhibitors (the DM-ACE patients) than that in the non DM-CKD patients who were being treated with ACE inhibitors (the non DM-ACE patients) (8.5+/-1.5 g/dL vs 10.8+/-1.6 g/dL, respectively, p=0.001). Multiple regression analysis indicated that serum IGF-1 concentration was independently associated with the Hb level (beta=0.425, p=0.02) in the DM-CKD patients.
CONCLUSIONS: The Hb concentration was significantly lower in the DM-CKD patients than that in the non DM-CKD patients. It was independently associated with the serum IGF-1 concentration in the DM-CKD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939336     DOI: 10.3904/kjim.2007.22.3.186

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   3.165


  5 in total

1.  The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia.

Authors:  Jie-Long Jiang; Wei Ren; Yan Li; Guang-Yi Liu; Cai-Ping Zhou; Ke-Liang Su; Wei Chen; Ke Wang; Li-Jun Ni; Zhao Hu
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

2.  The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Authors:  Imran Memon; Keith C Norris; Andrew S Bomback; Carmen Peralta; Suying Li; Shu-Cheng Chen; Peter A McCullough; Adam Whaley-Connell; Claudine Jurkovitz; Manjula Kurella Tamura; Georges Saab
Journal:  Cardiorenal Med       Date:  2013-06-01       Impact factor: 2.041

Review 3.  The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones.

Authors:  Marcello Maggio; Francesca De Vita; Alberto Fisichella; Fulvio Lauretani; Andrea Ticinesi; Graziano Ceresini; Anne Cappola; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Int J Endocrinol       Date:  2015-12-08       Impact factor: 3.257

4.  The impact of short daily hemodialysis on anemia and the quality of life in Chinese patients.

Authors:  J L Jiang; W Ren; J Song; Q L Sun; X Y Xiao; X Z Diao; Y H Huang; L Lan; P Wang; Z Hu
Journal:  Braz J Med Biol Res       Date:  2013-08-09       Impact factor: 2.590

Review 5.  Management of anemia in patients with diabetic kidney disease: A consensus statement.

Authors:  Sarita Bajaj; Brij Mohan Makkar; Vinod K Abichandani; Pradeep G Talwalkar; Banshi Saboo; S S Srikanta; Ashok Das; Sruti Chandrasekaran; P Venkata Krishnan; Arun Shah; Georgi Abraham; Pankaj Tikku; Sushil Kumar
Journal:  Indian J Endocrinol Metab       Date:  2016 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.